Search ( 6822 results )
- article
(Updated on )
Epidemiology of Ischemic Heart Disease in France
Introduction – Cardiovascular diseases are the leading cause of death worldwide. Ischemic heart disease (IHD), including acute coronary syndromes (ACS) with or without ST-segment...
- article
(Updated on )
Epidemiology of Strokes in France
Introduction – Nearly 10 years after the first National Stroke Plan (2010–2014), this study provides an overview of the epidemiology of strokes identified by the National Health Data...
- article
(Updated on )
Epidemiology of Heart Failure in France
Introduction – The objective of this study was to update the epidemiology of heart failure (HF) in France in 2022. Methods – Adults hospitalized for HF in 2022 were identified in the...
- article
(Updated on )
Epidemiology of Aortic and Peripheral Arterial Diseases in France in 2022
Introduction – Peripheral arterial diseases as a whole account for a significant proportion of morbidity and hospitalizations among patients with cardiovascular disease. Few...
- article
(Updated on )
Epidemiology of venous thromboembolism in France in 2022
Introduction – The objective of this article is to quantify venous thromboembolic events that occurred in France in 2022 and constituted the primary reason for hospitalization or...
- article
(Updated on )
Supplement. The National Health Data System (NHDS)
- article
Impact of smoking reduction scenarios on the burden of myocardial infarction in the French population by 2035
Impact of tobacco prevention scenarios on the burden of myocardial infarction in France in 2035.
- article
(Updated on )
Home testing kits for sexually transmitted infections: How are LGBT populations being addressed?
Introduction: Every day, more than one million people worldwide contract a sexually transmitted infection, which is asymptomatic in the majority of cases. In France, testing is primarily...
- article
(Updated on )
Assessment of Depression in a General Population Survey
A recent campaign by the National Institute for Prevention and Health Education (INPES) has raised public awareness about depressive disorders. The prevalence data used are based on...
- article
(Updated on )
Effectiveness of Nirsevimab in Cases of Respiratory Syncytial Virus Bronchiolitis Treated in Pediatric Intensive Care Units in France, September 2023–January 2024
In September 2023, France was one of the first countries to launch a national immunization campaign using nirsevimab, a new monoclonal antibody against respiratory syncytial virus (RSV)....